Associate Principal Scientist in Oral Formulation Research
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Is your ambition to do science for science, or science for people? Our Oral Formulation Research team is advancing oral treatments in all of Novo Nordisk’s therapeutic areas, our GLP-1 tablet formulation for type 2 diabetes being a recent example of success. As part of our multi-national team, you’ll bring your own ideas and collaborate with others on the development of new protein and peptide formulations, and the optimisation of existing ones. It’s ground-breaking work with the promise of improving the lives of millions of people with chronic conditions. If you want to make a difference, join us to do pioneering research that can impact people everywhere. The position We are growing and with that growth comes flexibility, innovation, freedom, and scientific drive for the life-changing benefit of patients. Oral drug delivery is a key component of our company’s strategy, and your role as Associate Principal Scientist is important for us to progress. Your main objective will be to formulate therapeutic proteins and peptides into oral solid dosage forms and participate in the development of innovative oral drug delivery systems. Innovation and scientific development are key parts of your role, you will handle specialist tasks of high complexity working partly in the lab, but also across functions and people to develop and optimize our research. By contributing with subject matter expertise in oral formulation and extensive business understanding, you drive innovation and project progression and provide input to project plans, data, scientific challenges, and deliberations. You demonstrate good stakeholder management and cross-collaboration. Working alongside talented international colleagues, you will share ideas and inspiration across different scientific areas. A part of your job will be to act as a mentor for junior colleagues within your field of expertise. Qualifications You hold a relevant PhD degree in Life Science (Pharmaceutical Science, Pharmacy, Chemistry, Medical Engineering, or related disciplines) and have a minimum of 5 years of experience in industry or academia including a couple of years’ focus on early-stage research. To be a successful candidate we expect you to have: A track record of innovative research within drug delivery and expertise in areas of an oral formulation Extensive experience in developing innovative drug delivery systems Experience with in vitro models and possibly in vivo testing of oral prototypes Insight into the physiology of the GI tract Business understanding and cross-functional stakeholder management skills Personally, you are driven by the basic tenet of science – to take on something that people think can’t be done, and to go way beyond where we are today. You apply your creativity to find solutions to the scientific challenges you encounter during your research, and you share knowledge and experience freely with other scientists, lab technicians and researchers to further our common cause. In exchange, we not only offer excellent multicultural work environment, but also a solid relocation package, very attractive healthcare, pension, competitive salary, bonus scheme, and multiple other benefits. About the department At Oral Formulation Research in Måløv, Denmark, you will join an international, ambitious and collaborative early research team. Our shared goal is to develop peptide and protein formulation concepts to enable oral drug delivery for type 2 diabetes as well as other chronic diseases. Long-term thinking drives our activities, and our research unit has been designed to provide the best scientific environment for the discovery and development of breakthrough medicines. Here, you will find the culture of ingenuity necessary to develop the next generation of life-saving therapies. Oral drug delivery is an important part of our company’s strategy, and we enjoy the full backing from top management that comes with it. Oral Therapies is one of the fastest growing areas in Novo Nordisk, representing the future of all our treatments and therapy areas. Do you want to hear more about who we are and how we work? Then see this video or click here to meet Maria, Philip, and Jian. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact If you have questions about the role, please contact Philip Christophersen +45 30791811 or Andrew Megarry +45 30792072. Deadline Are you ready to help transform treatment for a broad range of chronic diseases that currently rely on injectable-based therapies? Are you passionate about the development of new oral peptide and protein formulations and looking for new solutions to fight low permeability? Then send your application rather today than tomorrow, as we conduct interviews on an ongoing basis. The application deadline is January 31, 2022. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your CV. Please avoid the use of photos. This makes for a better and less biased process. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 17.10.2022, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
(Senior) IT Analyst, Application Maintenance area
Job ID: 21220 We are looking for a SWIFT IT Analyst who is self-driven, communicative, with good understanding of critical enterprise environments and importance of operational stability to rai..- Forretningsudvikler
- Taastrup
-
Business Developer with passion for process automa...
Job ID: 26825 Are you passionate about and have flair for process optimization through coding? And do you get top motivated by the thought of creating and driving the digital agenda? Then you may..- Forretningsudvikler
- København S
-
Clinical Publisher
Are you a fast learner and interested in clinical development and documentation? Do you have a quality mindset and a flair for learning new software? We are now looking for a Clinical Publisher for..- Forretningsudvikler
- Søborg
-
Project Manager, Lystrup or Søborg
[xxxxx] is facing an exciting future with considerable growth and demanding changes, as we deliver advanced technologies and mission critical solutions for the defense and aerospace industry. Our s..- Forretningsudvikler
- Søborg
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
Dato | Alle jobs som forretningsudviklere |
---|---|
4. november 2024 | 1 |
3. november 2024 | 3 |
2. november 2024 | 3 |
1. november 2024 | 3 |
31. oktober 2024 | 4 |
30. oktober 2024 | 4 |
29. oktober 2024 | 4 |
28. oktober 2024 | 4 |
27. oktober 2024 | 6 |
26. oktober 2024 | 6 |
25. oktober 2024 | 7 |
24. oktober 2024 | 7 |
23. oktober 2024 | 7 |
22. oktober 2024 | 8 |
21. oktober 2024 | 9 |
20. oktober 2024 | 12 |
19. oktober 2024 | 12 |
18. oktober 2024 | 11 |
17. oktober 2024 | 10 |
16. oktober 2024 | 10 |
15. oktober 2024 | 10 |
14. oktober 2024 | 10 |
13. oktober 2024 | 13 |
12. oktober 2024 | 13 |
11. oktober 2024 | 13 |
10. oktober 2024 | 12 |
9. oktober 2024 | 13 |
8. oktober 2024 | 12 |
7. oktober 2024 | 12 |
6. oktober 2024 | 15 |
5. oktober 2024 | 15 |